Management of anticoagulation-associated bleeds

That this House notes that an estimated 1.6 million people are living with atrial fibrillation in the UK; acknowledges that atrial fibrillation is a contributing factor in one in five strokes; welcomes the NHS’s commitment to improve the early detection and treatment of atrial fibrillation; further notes NHS England’s commitment to expand access to direct oral anticoagulants to help prevent 21,700 strokes and save 5,400 lives over a three-year period; further acknowledges that anticoagulants carry an increased risk of life-threatening bleeding, particularly within the gastrointestinal tract; recognises that the increase in anticoagulation medication will likely lead to an increased number of associated bleeds; further acknowledges the variation within the management of anticoagulation-associated bleeds; urges the National Institute for Health and Care Excellence to review and update clinical guidelines to improve outcomes within the management of anticoagulation-associated bleeds; and calls on NHS England to establish policies to reduce the variation within the management of anticoagulation-associated bleeds and improve patient outcomes.